Early taxane‐based chemotherapy and androgen deprivation therapy (ADT) vs ADT only
Adverse events grade 3 to 5 Range of
Early taxane‐based chemotherapy and androgen deprivation therapy (ADT) may leads to higher grade III to V adverse events compared with ADT only (low certainty).
1 finding from 1 review
- Taxane‐based chemohormonal therapy for metastatic hormone‐sensitive prostate cancer 2018 · Cochrane Headline outcomes onlyRR 2.98 [2.19, 4.04]1 study · 375 participantsLow